Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Brain Res ; 1481: 37-48, 2012 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-22917585

RESUMO

Polyglutamine (PolyQ) diseases have common features that include progressive selective neurodegeneration and the formation of protein aggregates. There is growing evidence to suggest that critical nuclear events lead to transcriptional alterations in PolyQ diseases such as spinocerebellar ataxia type 7 (SCA7) and Huntington's disease (HD), conditions which share a cerebellar degenerative phenotype. Taking advantage of laser capture microdissection technique, we compared the Purkinje cell (PC) gene expression profiles of two transgenic polyQ mouse models (HD: R6/2; SCA7: P7E) by microarray analysis that was validated by real time quantitative PCR. A large number of transcriptional alterations were detected in the R6/2 transgenic model of HD. Similar decreases in the same mRNAs, such as phospholipase C, ß 3, purkinje cell protein 2 (Pcp2) and aldolase C, were found in both models. A decrease in aldolase C and phospholipase C, ß 3, may lead to an increase in the vulnerability of PCs to excitotoxic events. Furthermore, downregulation of mRNAs mediated by the Pcp2-promoter is common in both models. Thus, our data reveal shared molecular abnormalities in different polyQ disorders.


Assuntos
Doença de Huntington/genética , Proteínas do Tecido Nervoso/genética , Peptídeos/genética , Células de Purkinje/fisiologia , Ataxias Espinocerebelares/genética , Animais , Ataxina-7 , Modelos Animais de Doenças , Feminino , Fatores de Troca do Nucleotídeo Guanina/genética , Humanos , Proteína Huntingtina , Doença de Huntington/patologia , Camundongos , Camundongos Transgênicos , Neuropeptídeos/genética , Análise de Sequência com Séries de Oligonucleotídeos , Regiões Promotoras Genéticas/genética , Células de Purkinje/patologia , Ataxias Espinocerebelares/patologia , Transcriptoma , Transgenes/genética
2.
Neurosci Lett ; 517(1): 7-12, 2012 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-22712074

RESUMO

Ataxia is a clinical feature of most polyglutamine disorders. Cerebellar neurodegeneration of Purkinje cells (PCs) in Huntington's Disease (HD) brain was described in the 1980s. PC death in the R6/2 transgenic model for HD was published by Turmaine et al. So far, PCs have not been examined on a single cell level. In order to begin to understand PC dysfunction and degeneration in HD we performed a gene expression study on laser-dissected PC based on a DNA microarray screening and quantitative real time PCR (Q-PCR). We demonstrate downregulation of the retinoid acid receptor-related orphan receptor (ROR) mRNA and ROR-mediated mRNAs, also seen by immunofluorescent staining. As ROR and ROR-dependent transcriptional dysregulation is not only found in the R6/2 model for HD but also in a model for spinocerebellar ataxia type 1 (SCA1) (Serra et al.) the data suggest common pathogenic mechanisms for both polyglutamine diseases.


Assuntos
Doença de Huntington/genética , Membro 1 do Grupo F da Subfamília 1 de Receptores Nucleares/genética , Células de Purkinje/citologia , Células de Purkinje/metabolismo , Animais , Cerebelo/metabolismo , Cerebelo/patologia , Modelos Animais de Doenças , Regulação para Baixo , Feminino , Doença de Huntington/metabolismo , Camundongos , Camundongos Transgênicos , Membro 1 do Grupo F da Subfamília 1 de Receptores Nucleares/metabolismo , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Ataxias Espinocerebelares/genética , Ataxias Espinocerebelares/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA